ProjectStartups.com

Recently Funded Startups

1056 startups tracked across markets and funding stages

Investor activity across stages, sectors, and geographies

FluoSphera

Develops human-based preclinical platform for drug safety and efficacy testing

Biotech Healthtech
€1.23M · 2026-01-12
Plan-les-Ouates, Switzerland

Inquis Medical

Develops mechanical thrombectomy systems for venous thromboembolic disease

Thrombectomy System Medical Device
Series C $75M · 2026-01-12
Menlo Park, California, United States

Juvena Therapeutics

Develops regenerative biologics to restore tissue function

Biotechnology Regenerative Medicine
Series B $33.5M · 2026-01-12
Redwood City, California, United States

Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

Biotechnology Immuno-Fibrotic Disease
Series B $250M · 2026-01-12
San Diego, California, United States

Nanochon

Develops implant for treating articular cartilage defects in the knee

Biotech Medical Device
Seed2 $4.1M · 2026-01-12
Washington DC, United States

Oricell Therapeutics

Develops next-generation cell therapies for solid tumors and hematologic malignancies

Biotechnology Cancer Immunotherapy
Series C1 $70M · 2026-01-12
Shanghai, China

OutSee

Develops AI-based predictive genomics approach to target discovery

Genomics Drug Discovery
Seed £2.5M · 2026-01-12
Cambridge, England, United Kingdom

Polar Light Technologies

Develops next-generation MicroLED technologies for display applications

MicroLED Semiconductor
€5M · 2026-01-12
Linkoping, Sweden, Sweden

PulseAI

Develops AI-enabled cardiac diagnostics platform for ECG interpretation

Healthcare Cardiac Diagnostics
Seed · 2026-01-12
Belfast, Northern Ireland, United Kingdom

Terra Industries

Designs infrastructure and autonomous systems to help governments and organizations monitor and r...

Defense AI/ML
Series A $11.75M · 2026-01-12
Abuja, Nigeria, Nigeria

Trailhead Biosystems

Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine

BioTech Drug Discovery
Growth $20M · 2026-01-12
Beachwood, Ohio, United States

Trybe

Provides spa, bathhouse, leisure, and activity management software

SaaS/Software Leisure
Series A $30M · 2026-01-12
London, England, United Kingdom

VelaFi

Provides stablecoin-powered financial infrastructure for global businesses

Fintech Payments
Series B $20M · 2026-01-12
Dallas, Texas, United States

Vibrant Therapeutics

Develops intelligent, logic-gated therapeutics for solid tumors

Biotechnology Therapeutics
Series A $61M · 2026-01-12
Guangzhou, China

VieCure

Provides intelligent software platforms for oncology care

Healthcare Oncology
$43M · 2026-01-12
Denver, Colorado, United States

Zepo Intelligence

Develops a workspace security platform combining human risk management with real-time threat dete...

Cybersecurity AI/ML
Seed $15M · 2026-01-12
New York, New York, United States

MagicCube

Provides software-based security for payments and device integrity

Fintech Payments
$10M · 2026-01-11
Santa Clara, California, United States

Torq

Empowers enterprises to instantly and precisely detect and respond to security events at scale

Cybersecurity AI/ML
Series D $140M · 2026-01-11
New York, New York, United States

Kinaset Therapeutics

Develops inhaled therapies for severe respiratory diseases

Biopharmaceutical Respiratory
Series B $103M · 2026-01-10
Boston, Massachusetts, United States

AirNexis Therapeutics

Develops therapeutics for pulmonary diseases, specifically COPD

Biotech Therapeutics
Series A $200M · 2026-01-09
Palo Alto, California, United States

bit.bio

Creates functional, human-relevant cells and models for research, drug discovery, and development

Biotech Drug Discovery
Series C $50M · 2026-01-09
Cambridge, England, United Kingdom

Brado

Provides Conversational Engagement Platform for patient navigation and engagement

Healthcare AI/ML
2026-01-09
St. Louis, Missouri, United States

Corgi Insurance

Provides AI-native, full-stack insurance for startups

Insurtech Fintech
Series A $108M · 2026-01-09
San Francisco, California, United States

Hadrian

Building next generation American factories for national reindustrialization

Manufacturing Aerospace
2026-01-09
Torrance, California, United States

Major Medical Devices

Develops innovative vascular intervention solutions for abdominal aortic aneurysms

MedTech Healthcare
Strategic · 2026-01-09
New York, New York, United States

MEDIPOST

Develops allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven deg...

Biotechnology Regenerative Medicine
$140M · 2026-01-09
Cambridge, Massachusetts, United States

Rain

Provides enterprise-grade infrastructure for stablecoin-powered payments

Fintech Payments
Series C $250M · 2026-01-09
New York, New York, United States

Ventaris Surgical

Develops a ureteroscopic system for complete kidney stone clearance

Medical Device Healthcare
Series A $30M · 2026-01-09
San Carlos, California, United States

Abbelight

Develops super-resolution microscopy end-to-end solutions

Bioimaging Microscopy
Series B · 2026-01-08
Paris, France

Alice

Develops AI platform for lawyers and legal teams to streamline casework

Legaltech AI/ML
Pre-Seed €1M · 2026-01-08
Bruges, Belgium

BrightHeart

Develops AI-powered prenatal ultrasound platform for expert-level fetal heart screening and conge...

AI/ML Healthcare
Series A €11M · 2026-01-08
Paris, France

Cyera

Provides AI and data security platform for enterprises

Data Security AI/ML
Series F $400M · 2026-01-08
New York, New York, United States

DeepSee

Provides agentic AI technology for financial services and capital markets firms to automate post-trade operations

Fintech AI/ML
Strategic · 2026-01-08
Draper, Utah, United States

Enhanced Digital Group Inc.

Provides derivatives solutions in the digital asset space for institutional clients

Digital Assets Derivatives Solutions
Series A · 2026-01-08
Park City, Utah, United States

Enodia Therapeutics

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Biotechnology AI/ML
Seed €20.7M · 2026-01-08
Paris, France

EpiBiologics

Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...

Protein Degradation Oncology
Series B $107M · 2026-01-08
San Mateo, California, United States